Amylyx Pharmaceuticals (AMLX) Receivables - Net (2022 - 2025)
Historic Receivables - Net for Amylyx Pharmaceuticals (AMLX) over the last 4 years, with Q3 2025 value amounting to $132000.0.
- Amylyx Pharmaceuticals' Receivables - Net fell 9237.44% to $132000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $132000.0, marking a year-over-year decrease of 9237.44%. This contributed to the annual value of $447000.0 for FY2024, which is 9888.39% down from last year.
- Per Amylyx Pharmaceuticals' latest filing, its Receivables - Net stood at $132000.0 for Q3 2025, which was down 9237.44% from $103000.0 recorded in Q2 2025.
- In the past 5 years, Amylyx Pharmaceuticals' Receivables - Net ranged from a high of $40.0 million in Q4 2023 and a low of $103000.0 during Q2 2025
- In the last 4 years, Amylyx Pharmaceuticals' Receivables - Net had a median value of $4.1 million in 2024 and averaged $12.5 million.
- As far as peak fluctuations go, Amylyx Pharmaceuticals' Receivables - Net soared by 2132554.74% in 2023, and later plummeted by 9888.39% in 2024.
- Over the past 4 years, Amylyx Pharmaceuticals' Receivables - Net (Quarter) stood at $15.3 million in 2022, then soared by 161.66% to $40.0 million in 2023, then plummeted by 98.88% to $447000.0 in 2024, then plummeted by 70.47% to $132000.0 in 2025.
- Its Receivables - Net was $132000.0 in Q3 2025, compared to $103000.0 in Q2 2025 and $300000.0 in Q1 2025.